B57 - Babesiosis
ICD-10 B57 is a billable code used to indicate a diagnosis of b57 - babesiosis.
Babesiosis is a malaria-like parasitic disease caused by protozoa of the genus Babesia, primarily transmitted through the bite of infected Ixodes ticks. The disease is characterized by symptoms such as fever, chills, sweats, headache, body aches, loss of appetite, and nausea. In severe cases, it can lead to hemolytic anemia, thrombocytopenia, and multi-organ dysfunction, particularly in immunocompromised individuals or those without a spleen. Babesiosis is endemic in certain regions, particularly in the northeastern and upper midwestern United States, and is often associated with Lyme disease due to the overlapping habitats of the ticks that transmit these infections. Diagnosis is typically confirmed through blood smear microscopy or serological tests. Treatment usually involves the use of antimalarial medications such as atovaquone combined with azithromycin or clindamycin combined with quinine, depending on the severity of the disease. Prompt diagnosis and treatment are crucial to prevent complications and improve patient outcomes.
Detailed patient history, including travel and exposure history, laboratory results, and treatment response.
Patients presenting with fever and recent travel to endemic areas, or those with tick exposure.
Ensure all relevant lab tests are documented to support diagnosis.
Comprehensive patient history and physical examination findings, including symptoms and any relevant travel history.
Patients with flu-like symptoms after outdoor activities in endemic regions.
Documenting the timeline of symptoms and any potential tick exposure is crucial.
Used when confirming a diagnosis of babesiosis.
Document the reason for testing and results.
Infectious disease specialists should ensure comprehensive lab documentation.
Common symptoms include fever, chills, sweats, headache, body aches, loss of appetite, and nausea. Severe cases may lead to hemolytic anemia and multi-organ dysfunction.
